Pharmacy Daily | Viral Hep conference

THIS year the Australasian Viral Hepatitis Conference will be held in Melbourne between 6-8 Sep. Highlights of the conference include discussion of Gene Therapy and the discovery of the gene IL28B which allows doctors to predict how well a hep C patient will respond to treatment and also presentations looking into the low levels of hepatitis C treatment uptake in Australia (incl. barriers between people with the disease and treatment, difficulties gaining access to treatment and fresh roles by healthcare practitioners). Also on the conference agenda is the “often overlooked issue of epidemiology of hepatitis B in the community’, as well as ‘Moving Forward - Challenges for the Next Decade’. Hundreds of healthcare professionals including GPs, specialists and members of the pharmaceutical community are set to attend the conference - for information on the program or registration see www.hepatitis.org.au.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 27 Aug 10
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Aug 10